What Is Tranexamic Acid? Its Use in Spot Care
Tranexamic acid is a lysine-derived drug used to reduce bleeding; its topical forms can support uneven tone and the appearance of melasma by suppressing the plasmin pathway that stimulates melanin production. Small studies reported mild or moderate improvement at ratios of 2-5% and good tolerance. Evaluation requires 8-12 weeks and strict sun protection; only a doctor plans the oral form.
At a glance
- INCI name
- Tranexamic Acid
- Type
- Synthetic derivative of the amino acid lysine, actually a drug
- What it does
- Supports the look of uneven tone and melasma; suppresses the plasmin pathway
- Typical concentration
- 1,8-5% in studies; superiority of 5% over 2% has not been shown
- How to use
- After cleansing, before moisturizer; 8-12 weeks, with sun protection
- Caution
- Consult your doctor first if you have a history of blood clots, or if you are pregnant or breastfeeding
What's on this page?
- How does tranexamic acid work on skin tone?
- What is known for which spot?
- Cream, pill, injection: The same molecule, different risk
- 2%, 3%, 5%: What do the ratios mean?
- What should you look for on the label?
- Tranexamic acid or another agent?
- Combined use: Which agents fit in the same routine?
- When should you expect results?
- Three questions about tranexamic acid
- Who should be careful?
Tranexamic acid is a substance that can help reduce uneven tone and the appearance of melasma by suppressing the plasmin pathway that triggers melanin production. Topical forms have been tested in small studies at ratios such as 2-5%, often with results close to prescription hydroquinone and reports of better tolerance. Still, the topical form is more limited in effect than the oral form used by doctors. Results require 8-12 weeks of regular use and strict sun protection.
How does tranexamic acid work on skin tone?
This substance is actually a drug. It is a synthetic derivative of the amino acid lysine, used to reduce bleeding. Its use for spots began with observations in melasma, and it is still off-label in many countries.
The sequence can be summarized as follows: sun and hormones convert plasminogen to plasmin in the surface cells of the skin. Plasmin in turn increases the signals that stimulate the tyrosinase enzyme in melanin-producing cells. Tranexamic acid settles where plasminogen would bind, reducing this conversion. It may also reduce plasmin-related vascular growth signals, so it is suggested that it can act on the vascular side of melasma as well.
This mechanism is not yet certain. There are also laboratory studies reporting a direct relation to tyrosinase. The main data for clinical decisions are the patient studies in the following sections.
What is known for which spot?
"Spots" are not a single problem, and the data is not equally strong for all of them. First you need to understand the type of spot. The skin spots guide explains this distinction.
| Situation | What is known? | Realistic expectation |
|---|---|---|
| Melasma | Most of the studies are on this. The topical form has been compared with hydroquinone, often with close results | Mild or moderate improvement, may recur |
| Dark mark after acne | Few and small studies; a similar result to azelaic acid has been reported | Help in appearance, evidence limited |
| Uneven tone, sun spots | 35 person 2% serum study, 8 weeks, no control group | Low expectation; sun protection is the main step |
| Freckles, changing mole, raised spot | There is no evidence for use in this target | A changing spot requires an examination |
Cream, pill, injection: The same molecule, different risk
The serum you see on the shelf and the form a doctor prescribes are not the same thing. A review of 46 publications on melasma also rates the applied form as the least effective route and the oral form as the most effective. But oral use is a serious decision.
| Form | Level of effect | Common ones | Decision |
|---|---|---|---|
| Topical serum, cream | Mild or moderate, may be strengthened with other agents | Mild redness, dryness, stinging | You can try it yourself for mild uneven tone. If melasma is suspected, ask a doctor |
| Oral (prescription) | Strongest result in studies | Stomach complaints, menstrual changes, headache. Clot risk should be evaluated | Dose and suitability are determined only by a doctor |
| Injection into the skin | Studied; recurrence reported after stopping | Injection site complaints | Only in the clinic, by the doctor's decision |
| Application with microneedles and laser | Small studies, mixed results | Irritation after procedure, risk of dark spots | Not done at home |
Factors such as a history of blood clots, cardiovascular disease, hormone use or smoking are important for the oral form. Do not obtain and use this drug from an acquaintance or the internet. It is also wise to tell your doctor about these histories when using the topical product.
2%, 3%, 5%: What do the ratios mean?
There is no direct comparison study looking for the most suitable ratio. We have separate studies testing different ratios in different formulas.
| Form | Study | Result | Note |
|---|---|---|---|
| 1,8% liposomal | 60 people, 12 weeks | Less decrease in melanin index compared with the hydroquinone and microneedle arms; improvement greater than 50% at 27,8% | Cosmetic-like but a special carrier |
| 2% emulsion and leaf mask | 23 people, 12 weeks | Improvement in 22 of 23 people, progress mostly in the first 8 weeks | No control group |
| 3% cream | Melasma, comparison with hydroquinone | Similar severity reduction, better tolerance | Limited reporting of numbers |
| 5% cream | 60 people, 12 weeks | No significant difference from hydroquinone, fewer side effects | The hydroquinone ratio compared was low |
| 5% solution | 100 people, 12 weeks | Melasma score decreased by about 27%, similar to hydroquinone | No placebo group |
Three things can be taken from this table. First, in studies without a placebo comparison, it is possible that part of the improvement came from sun protection. Second, it has not been shown that 5% is superior to 2%; do not think 'higher is better'. Third, the carrier formula matters: the same ratio does not behave the same way in every serum.
What should you look for on the label?
- Name: The ingredient list says "Tranexamic Acid." Derivative forms are also sold, but since most of the studies above were done with the acid itself, you cannot project the same results onto derivatives.
- Ratio: A product that explains its ratio makes comparison easier. But stating 5% does not mean better results; the ratio alone does not determine quality.
- Fragrance and alcohol: Since irritation can make spots worse, a fragrance-free formula is more reasonable for a spot product.
- Multi-ingredient serums: Products that come with niacinamide or acid can be practical. But check whether you are reapplying the same actives with another product; this can increase irritation.
Tranexamic acid or another agent?
There is no single winner in spot care. The choice depends on the type of spot, skin tolerance and whether you are under doctor supervision. Because there is very little direct comparison among these agents, the table is not a definitive ranking.
| Agent | What does it target? | Caution |
|---|---|---|
| Tranexamic acid | Plasmin pathway | Data on the topical form is small, tolerance is good |
| Azelaic acid | Tyrosinase, inflammation | Strong ratios are drugs and can sting |
| Niacinamide | Intercellular transport of pigment | Small studies, gentle |
| Vitamin C | Antioxidant, tyrosinase | May be unstable and may irritate |
| Arbutin and kojic acid | Tyrosinase | Allergy reported with kojic acid |
| Hydroquinone | Tyrosinase | Prescription, its use is planned by a doctor |
Combined use: Which agents fit in the same routine?
Data on combinations is limited, but reviews that find topical tranexamic acid insufficient on its own see more hope in using it with other agents. A short framework:
- Niacinamide and alpha arbutin: In a 44-person three-arm study, serums containing both improved brightness and pigment in 4 weeks, with no difference from hydroquinone. Since it is multi-ingredient, the source of the effect cannot be separated.
- Vitamin C: In a liposomal lotion, benefit was reported in the look of melasma together with a vitamin C derivative and vitamin E. It is not possible to recreate the same formula at home. If you use separate serums and one causes itching, separate them.
- Retinol, glycolic and salicylic acid: Direct studies are few. The real risk is accumulated irritation, since irritation can worsen a spot. Do not apply them one after another on the same evening; split them across different evenings.
- Prescription spot treatment: Ask your doctor before adding anything to a product they have prescribed.
Steps when adding to your routine
- Try first. On the inner arm or elbow crease, twice a day, for 7-10 days. Stop if there is itching, swelling or marked redness.
- One new product. Do not start other new products in the same period.
- Place it in the serum step. After cleansing, before moisturizer, in a thin layer. If the label gives a frequency, follow it; most studies used it 1-2 times a day.
- Add sunscreen. Apply a broad-spectrum product with at least SPF 30, and reapply every 2 hours and after sweating or swimming. For melasma, take visible light into account too; you can read about the role of tinted products in the melasma article. Do not overlook the right amount either.
When should you expect results?
Most studies last 8-12 weeks, so there is no point in deciding earlier. In a small study, the improvement was reported to be mostly in the first 8 weeks, slowing toward week 12. If there is no difference after 12 weeks, see a dermatologist to discuss a different option.
What happens when you stop? Long-term follow-up data for the applied form is scarce. Melasma can recur by nature; in a very small pilot study where injections were applied, the recurrence rate reached 60% at week 48. So this ingredient does not permanently remove the spot. If sun protection is not continued, the improvement gained may come back.
Three questions about tranexamic acid
Is it safer than hydroquinone?
Topical tranexamic acid was better tolerated in studies. This means "fewer side effects"; it does not mean long-term safety has been proven, because follow-up periods are mostly 12 weeks. If you want to use it in place of a prescription product such as hydroquinone, ask your doctor.
Should I stop using it in summer?
You do not need to stop this ingredient. Since the main trigger is the sun, tightening sun protection in summer matters more. On beach or outdoor days, include a hat and shade in your plan.
Can I stop when I get results?
You can stop, but melasma spots may recur. Keep up sun protection after improvement; if they return, go back to the same steps or a doctor's evaluation. Since there is little long-term data on how safe continuous use is, it is good to discuss this decision with your doctor.
Who should be careful?
- Pregnancy and breastfeeding: The reviews we have do not provide safety information on the topical form for this period. Melasma is common in pregnancy, but do not start on your own; consult your doctor.
- Those with a history of blood clots: Tell your doctor even before using a topical product. Oral use requires particular caution in these people.
- Sensitive and eczema-prone skin: Do not add a new active while there is stinging or redness. First restore the barrier.
- Dark skin: The risk of dark spots after irritation is higher; make the decision about laser and microneedling in the clinic.
- Spot with uncertain diagnosis: For spots that change in shape, color or border, or that bleed or crust, get examined first.
This page is for general information only and does not replace medical diagnosis or treatment. If you have an ongoing skin or scalp problem, consult a dermatologist.